抑制剂:
δENaC, AE3, AQP1, AQP12, AQP12A, AQP12B, AQP2, AQP3, AQP4, AQP6, ATAD4, BC048943, BOCT, C20orf111, C4ST-2, C8orf5, CA III, CA IV, CHMP4A, claudin-2, CLC-3, CLC-4, CLC-6, CLC-K1, CLCA3_Clac3, CLIC5, cyclin M3, DFNB59, FXYD7, GABA Receptor, GABAA R rho 1, GABAA Rβ2, GABAA Rδ, GABAA Rε, GABAA Rγ2, GABAA Rρ3, GABAA Rp, GABAC Rρ3, Glut9, Glycophorin A, GPR89, KCC1, KCC2a, KCC2b, KCC3, KCC4, LHFPL5, LRRC8D, MFSD6L, MFSD9, Mmgt2, MRS2L, Na+ CP type XIα, NCBE, NHEDC2, NKAIN1, NKCC, NKCC1, NKHC1, NPT1, OAT, OAT1, OAT2, OAT3, OAT6, Oatp3, Olfr509, Olfr666, Olfr667, Olr1499, Olr1514, Olr1646, Olr208, Olr213, Olr245, Olr34, Olr395, Olr419, OPG, OSR1, PIPES, Prestin, RDS, Relaxin 1, RENBP, RFC-1, RhAG, SLC12A8, SLC12A9, SLC17A (solute carrier family 17), SLC17A2, SLC17A4, SLC22A11, SLC22A14, SLC22A23, SLC22A29, SLC22A9, SLC26A11, SLC26A6, SLC41A1, spectrin, spectrin αII, Stereocilin, SVCT3, TMC2, TMEM14A, TMEM63B, TMIE, UST1R, WNK1, 和 WNK3.